CHA Biotech Co. Ltd - Asset Resilience Ratio

Latest as of June 2026: 2.13%

CHA Biotech Co. Ltd (085660) has an Asset Resilience Ratio of 2.13% as of June 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See working capital position of CHA Biotech Co. Ltd to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

₩60.88 Billion

≈ $41.26 Million USD Cash + Short-term Investments

Total Assets

₩2.86 Trillion

≈ $1.94 Billion USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2008–2025)

This chart shows how CHA Biotech Co. Ltd's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see how large is CHA Biotech Co. Ltd's balance sheet.

Liquid Assets Composition Over Time

This chart breaks down CHA Biotech Co. Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore investment intensity of CHA Biotech Co. Ltd to see how much of total assets are deployed in long-term investments.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	₩0.00	0%
Short-term Investments	₩60.88 Billion	2.13%
Total Liquid Assets	₩60.88 Billion	2.13%

Asset Resilience Insights

Limited Liquidity: CHA Biotech Co. Ltd maintains only 2.13% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

CHA Biotech Co. Ltd Industry Peers by Asset Resilience Ratio

Compare CHA Biotech Co. Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
ALK-Abelló A/S CO:ALK-B	Biotechnology	0.98%
Mirum Pharmaceuticals Inc NASDAQ:MIRM	Biotechnology	6.89%
Xiamen Amoytop Biotech Co Ltd SHG:688278	Biotechnology	4.69%
BB Biotech AG SW:BION	Biotechnology	92.97%
Soleno Therapeutics Inc NASDAQ:SLNO	Biotechnology	20.15%
Nanobiotix NASDAQ:NBTX	Biotechnology	4.71%
Wuhan Keqian Biology Co Ltd SHG:688526	Biotechnology	19.42%
Beijing Konruns Pharmaceutical Co Ltd SHG:603590	Biotechnology	10.55%

Annual Asset Resilience Ratio for CHA Biotech Co. Ltd (2008–2025)

The table below shows the annual Asset Resilience Ratio data for CHA Biotech Co. Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	3.99%	₩101.67 Billion ≈ $68.90 Million	₩2.55 Trillion ≈ $1.73 Billion	-0.75pp
2024-12-31	4.74%	₩104.10 Billion ≈ $70.55 Million	₩2.19 Trillion ≈ $1.49 Billion	-4.59pp
2023-12-31	9.34%	₩161.09 Billion ≈ $109.17 Million	₩1.73 Trillion ≈ $1.17 Billion	-5.49pp
2022-12-31	14.83%	₩238.32 Billion ≈ $161.51 Million	₩1.61 Trillion ≈ $1.09 Billion	-6.59pp
2021-12-31	21.43%	₩328.90 Billion ≈ $222.89 Million	₩1.54 Trillion ≈ $1.04 Billion	-4.75pp
2020-12-31	26.17%	₩343.83 Billion ≈ $233.01 Million	₩1.31 Trillion ≈ $890.28 Million	+0.99pp
2019-12-31	25.18%	₩292.86 Billion ≈ $198.47 Million	₩1.16 Trillion ≈ $788.10 Million	-0.10pp
2018-12-31	25.29%	₩239.59 Billion ≈ $162.36 Million	₩947.53 Billion ≈ $642.13 Million	-9.23pp
2017-12-31	34.52%	₩273.95 Billion ≈ $185.65 Million	₩793.61 Billion ≈ $537.82 Million	-7.57pp
2016-12-31	42.09%	₩323.62 Billion ≈ $219.31 Million	₩768.93 Billion ≈ $521.09 Million	+26.34pp
2015-12-31	15.75%	₩101.53 Billion ≈ $68.80 Million	₩644.83 Billion ≈ $436.99 Million	+2.24pp
2014-12-31	13.50%	₩83.85 Billion ≈ $56.82 Million	₩620.88 Billion ≈ $420.76 Million	-13.12pp
2013-12-31	26.63%	₩182.51 Billion ≈ $123.68 Million	₩685.47 Billion ≈ $464.53 Million	+6.88pp
2012-12-31	19.75%	₩102.39 Billion ≈ $69.39 Million	₩518.47 Billion ≈ $351.36 Million	-2.98pp
2011-12-31	22.73%	₩107.96 Billion ≈ $73.16 Million	₩475.02 Billion ≈ $321.91 Million	+18.93pp
2010-12-31	3.80%	₩12.70 Billion ≈ $8.60 Million	₩334.30 Billion ≈ $226.55 Million	-1.74pp
2009-12-31	5.54%	₩12.65 Billion ≈ $8.57 Million	₩228.35 Billion ≈ $154.75 Million	-24.92pp
2008-12-31	30.45%	₩31.64 Billion ≈ $21.44 Million	₩103.88 Billion ≈ $70.40 Million	--

pp = percentage points

About CHA Biotech Co. Ltd

KQ:085660 Korea Biotechnology

Market Cap

$490.17 Million

₩723.30 Billion KRW

Market Cap Rank

#12423 Global

#351 in Korea

Share Price

₩7780.00

Change (1 day)

-0.64%

52-Week Range

₩7780.00 - ₩23850.00

All Time High

₩40950.00